Close Glentham Life Sciences login box

Settings

Login or Register
Choose your language
Close Glentham Life Sciences login box
Login:

Forgot your password?
Don't have an account yet? Click here to register...
Close currency selection box
Choose your currency:



Close language selection box
Choose your country or region:
Australia
Austria
Belgium
Canada
Czech Republic
Denmark
Finland
France
Germany
Hungary
Ireland
Israel
Italy
Japan
Korea South
Netherlands
New Zealand
Norway
Poland
Portugal
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
United States
Vietnam
Choose your language:

GA3583 Cefotaxime sodium salt

Synonyms: Cefotaxim sodium salt; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(acetyloxy)methyl-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo, monosodium salt, [6R-[6α,7 β (Z)]]-; Sodium (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7[2]-(Z)-(O-methyloxime), acetate (ester)

CAS:64485-93-4
MF:C16H16N5NaO7S2
MW:477.40
CAS:64485-93-4
Molecular Formula:C16H16N5NaO7S2
Molecular Weight:477.40
Availability: In stock
Pricing (USD - $)
GA3583-1G 1g
$80.00
GA3583-5G 5g
$152.00
GA3583-25G 25g
$472.00
GA3583 BULK
MSDSDownload MSDS
  
Certificate of AnalysisDownload Certificate of Analysis
Product Detail
Glentham CodeGA3583
Product NameCefotaxime sodium salt
Product Categories APIs   Antibiotics   Biochemicals   Raw Materials (IVD)  
CAS64485-93-4
EC Number264-915-9
Molecular Formula C16H16N5NaO7S2
Molecular Weight 477.40
Storage Details +4°C
Harmonised Tariff Code 2941900000
Product SpecificationDownload specification
Physical Description White, off-white or pale yellow crystalline powder
Identification According to USP
Solubility (10% in water) Clear, colourless to yellow solution
Absorbance 430nm: ≤ 0.20
Specific Optical Rotation 58 - 64 °
pH (10% in water) 4.5 - 6.5
Loss on Drying ≤ 3.0%
Organic Impurities Individual impurities: ≤ 1.0%
Total impurities: ≤ 3.0%
Assay 916 - 964 μg/mg (C16H17N5O7S2, dried basis)
Pharmacopoeia Specification(s) USP
Specification Version 1.0
Hazard Information
Pictograms
Signal word Danger
Hazard statements H317: May cause an allergic skin reaction.
H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements P261: Avoid breathing dust/fume/gas/mist/vapours/spray.
P285: In case of inadequate ventilation wear respiratory protection.
P304 + P341: IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342 + P311: If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Further product information and references
MDL Number MFCD00079073
Additional CAS 63527-52-6 (acid)
PubChem SID 310269492
Copyright © 2013-2017
Glentham Life Sciences Limited
Registered in England & Wales: 08553103

All rights reserved

Glentham Life Sciences Facebook page Glentham Life Sciences Twitter page Glentham Life Sciences Google Plus page Glentham Life Sciences LinkedIn page
Glentham Life Sciences Ltd
Unit 5 Ingoldmells Court
Edinburgh Way
Corsham
Wiltshire
SN13 9XN
United Kingdom

Tel: +44 (0) 1225 667798
Fax: +44 (0) 2033 978909
Email: info@glentham.com